a matchmaking service for patients and trials
quite interesting even if now yet add... - Advanced Prostate...
quite interesting even if now yet addressing PCa: huge uk trial
Written by
Maxone73
To view profiles and participate in discussions please or .
1 Reply
•
Seems like a nice public health and private industry collaboration with the potential to help speed delivery of trial therapies to patients with limited options.
Not what you're looking for?
You may also like...
UK TV programme - PCa Trial
Hello from York, Yorkshire, UK.
One of our TV channels, BBC Two, has shown a series of programmes...
Adding carboplatin to chemotherapy for mCRPC in post-second generation hormone therapy setting: Impact on response and survival
New study below. [1]
"We retrospectively identified 150 mCRPC patients with disease progression on...
COVID Booster risk/benefit
I'm curious how your docs are advising you on whether to get a COVID booster. (I'm interested what...
Diethylstilbestrol when faced with "economic constraint".
New study below [1].
We see so many posts on Zytiga, Xtandi & even more expensive drugs. This...
Cancer patients using complementary medicine more likely to die because they delay or skip real treatment. Hard Data Backing This Up!
Quackery is not Victimless. Come on you knew it. Now here is the hard data.
1. Cancer...
Related Posts
!Beware of quack docs!
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen- Oh guys, this one is good for mCRPC: Biologic Drug-Device Combination Immunotherapy Shows Promise for Patients with mCRPC
- Statin use in advanced PCA with ADT or abiraterone/enzalutamide
Low PSA levels are associated with greater prostate cancer-specific mortality among men with a Gleason score of 8 to 10
